Jeffrey Day, CEO

Jeff is a seasoned specialty pharma executive with 31 years of experience in the dermatology and related markets. In 2013, he established and ran Intraderm Pharmaceuticals as its President. Previously in 2017 he was the founder and CEO of Quinnova Pharmaceuticals and built, funded and eventually managed the sale of Quinnova to Amneal Pharma and Exceltis (CHEMO Pharmaceuticals). Mr. Day has held strategic sales, marketing, and business development positions with major pharmaceutical companies. Jeff is a commercialization expert with strong ties with the KOL Dermatologists and extenders and also has strong development expertise with multiple 510(k) approvals and a 505(b)(2) approval.